The rationale for the use of dopamine agonists in parkinson's disease

1. Jenner, P.
2. Schwartz, J.-C.
3. Giros, N.
4. Matres, M.-P.
5. Sibley, D.R.
6. Monsma, F.J.
7. Sokoloff, P.
8. Martres, M.-P.
9. Giros, B.
10. Martin, G.E.
11. Williams, M.
12. Pettibone, D.J.
13. Nomoto, M.
14. Stahl, S.
15. Jenner, P.
16. Coleman, R.J.
17. Lange, K.W.
18. Quinn, N.P.
19. Loschmann, P.-A.
20. Chong, P.N.
21. Nomoto, M.
22. Setler, P.E.
23. Sarau, H.M.
24. Zirkle, C.L.
25. Nomoto, M.
26. Jenner, P.
27. Marsden, C.D.
28. Barone, P.
29. Bankiewicz, K.S.
30. Corsini, G.U.
31. Nomoto, M.
32. Jenner, P.
33. Marsden, C.D.
34. Braun, A.
35. Fabbrini, G.
36. Mouradian, M.M.
37. Temlett, J.A.
38. Chong, P.N.
39. Oertel, W.H.
40. Quinn, N.P.
41. Jenner, P.G.
42. Kebabian, J.W.
43. Britton, D.R.
44. De Ninno, M.P.
45. Taylor, J.R.
46. Lawrence, M.S.
47. Redmond, D.E.
48. Vermeulen, R.J.
49. Drukarch, B.
50. Sahadat, M.C.R.
51. Schwartz, J.-C.
52. Levesque, D.
53. Andrieux, M.
54. Besancon, R.
55. Bedard, P.J.
56. Di Paolo, T.
57. Falardeau, P.
58. Luquin, M.R.
59. Laguna, J.
60. Obeso, J.A.
61. Gomez-Mancilla, B.
62. Blanchet, P.
63. Britton, D.R.
64. Crossman, A.R.
65. Voorn, P.
66. Roest, G.
67. Groenewegen, H.J.
68. Gerfen, C.R.
69. Engber, T.M.
70. Susel, Z.
71. Jenner, P.
72. Jenner, P.
73. Schapira, A.H.V.
74. Marsden, C.D.
75. Saggu, H.
76. Cooksey, J.
77. Dexter, D.
78. Marttila, R.J.
79. Lorentz, H.
80. Rinne, U.K.
81. Marklund, S.F.
82. Adolfsson, R.
83. Gottfries, C.G.
84. Rosen, D.R.
85. Siddique, T.
86. Patterson, D.
87. Ceballos, I.
88. Lafon, M.
89. Javoy-Agid, F.
90. Clow, A.
91. Hussain, T.
92. Glover, V.
93. Carrillo, M.-C.
94. Kanai, S.
95. Nokubo, M.
96. Freestone, C.
97. Lewis, E.
98. Felten, D.L.
99. Felten, S.Y.
100. Fuller, R.W.
101. Yoshikawa, T.
102. Minamiyama, Y.
103. Naito, Y.
104. Ubeda, A.
105. Montesinos, C.
106. Paya, M.
107. Mostrar todos los/as autores/as +